Clinical, molecular, and genetic characteristics of PAPA syndrome: A review

Current Genomics

Volumn 11, Issue 7, 2010, Pages 519-527

  Smith, Elisabeth J ^a,b   Allantaz, Florence ^c   Bennett, Lynda ^c   Zhang, Dongping ^a   Gao, Xiaochong ^a   Wood, Geryl ^d   Kastner, Daniel L ^d   Punaro, Marilynn ^a   Aksentijevich, Ivona ^d   Pascual, Virginia ^c   Wise, Carol A ^a  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Anakinra; Auto inflammatory disease; CD2BP1; IL 1 ; Microarray transcript profiling; Neutrophils; PAPA syndrome; PSTPIP1; PTP PEST; Pyrin

Indexed keywords

BINDING PROTEIN; CD2 BINDING PROTEIN 1; INFLAMMASOME; INTERLEUKIN 1BETA; PHOSPHATASE; PROLINE SERINE THREONINE PHOSPHATASE INTERACTING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 15Q; CLINICAL FEATURE; CYTOKINE PRODUCTION; GENE MUTATION; HEREDITY; HUMAN; PAPA SYNDROME;

EID: 78650006414     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210793175921     Document Type: Article

References (68)

1. Kastner, D.L. O'Shea, J.J. A fever gene comes in from the cold. Nat. Genet., 2001, 29, 241-242.
2. McDermott, M.F.; Aksentijevich, I.; Galon, J.; McDermott, E.M.; Ogunkolade, B.W.; Centola, M.; Mansfield, E.; Gadina, M.; Karenko, L.; Pettersson, T.; McCarthy, J.; Frucht, D.M.; Aringer, M.; Torosyan, Y.; Teppo, A.M.; Wilson, M.; Karaarslan, H.M.; Wan, Y.; Todd, I.; Wood, G.; Schlimgen, R.; Kumarajeewa, T.R.; Cooper, S.M.; Vella, J.P.; Amos, C.I.; Mulley, J.; Quane, K.A.; Molloy, M.G.; Ranki, A.; Powell, R.J.; Hitman, G.A.; O'Shea, J.J.; Kastner, D.L. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 1999, 97, 133-144.
3. Masters, S.L.; Simon, A.; Aksentijevish, I.; Kastner, D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol., 2009, 27, 621-668.
4. Aksentijevich, I.; Deng, Z.; Sood, R.; Balow, Jnr. J.E.; Wood, G.; Zaks, N.; Mansfield, E.; Tiqva, P.; Chen, X.; Eisenberg, S.; Vedula, A.; Shafran, N; Raben, N.; Pras, E.; Pras, M.; Richards, N.; Shelton, D.A.; Kastner, D.L.; Gumucio, D.; Yokoyama, C.Y.; Mangelsdorf, M.; Orsborn, A.; Richards, R.I.; Blake, T.; Baxevanis, A.D.; Robbins, C.; Krizman, D.; Collins, F.S.; Liu, P.; Ricke, D.O.; Buckingham, J.M.; Moyzis, R.K.; Deavan, L.L.; Doggett, N.A.; Chen, X.; Shohat, M.; Hamon, M.; Kahan, T. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell, 1997, 90, 797-807.
5. Drenth, J.P.; Cuisset, L.; Grateau, G.; Vasseur, C.; van de Velde-Visser, S.D.; De Jong, J.G.; Beckmann, J.S.; van der Meer, J.W.; Delpech, M. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper- IgD Study Group. Nat. Genet., 1999, 22, 178-181.
6. Houten, S.M.; Kuis, W.; Duran, M.; de Koning, T.J.; van Royen-Kerkhof, A.; Romeijn, G.J.; Frenkel, J.; Dorland, L.; de Barse, M.M.; Huijbers, W.A.; Rijkers, G.T.; Waterham, H,R.; Wanders, R.J.; Poll-The, B.T. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat. Genet., 1999, 22,175-177.
7. Hoffman, H.M.; Mueller, J.L.; Broide, D.H.; Wanderer, A.A.; Kolodner, R.D. Mutation of a new gene encoding a putative pyrinlike protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet., 2001, 29, 301-305.
8. Aksentijevich, I.; Masters, S.L.; Ferguson, P.J.; Dancey, P.; Frenkel, J.; van Royen-Kerkhoff, A.; Laxer, R.; Tedgård, U.; Cowen, E.W.; Pham, T.H.; Booty, M.; Estes, J.D.; Sandler, N.G.; Plass, N.; Stone, D.L.; Turner, M.L.; Hill, S.; Butman, J.A.; Schneider, R.; Babyn, P.; El-Shanti, H.I.; Pope, E.; Barron, K.; Bing, X.; Laurence, A.; Lee, C.C.; Chapelle, D.; Clarke, G.I.; Ohson, K.; Nicholson, M.; Gadina, M.; Yang, B.; Korman, B.D.; Gregersen, P.K.; van Hagen, P.M.; Hak, A.E.; Huizing, M.; Rahman, P.; Douek, D.C.; Remmers, E.F.; Kastner, D.L.; Goldbach-Mansky, R. An autoinflammatory disease with deficiency of the interleukin- 1-receptor antagonist. N. Engl. J. Med., 2009, 360, 2426-2437.
9. Reddy, S.; Jia, S.; Geoffrey, R.; Lorier, R.; Suchi, M.; Broeckel, U.; Hessner, M.J.; Verbsky, J. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N. Engl. J. Med., 2009, 360, 2438-2444.
10. Miceli-Richard, C.; Zouali, H.; Lesage, S.; Thomas, G.; Hugot, J.P.; Said-Nahal, R.; Breban, M. CARD15 mutations in Blau syndrome. Nat. Genet., 2001, 29, 19-20.
11. Kanazawa, N. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood, 2005, 105, 1195-1197.
12. Meissner, F.; Seger, R.A.; Moshous, D.; Fischer, A.; Reichenbach, J.; Zychlinsky, A. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood, 2010, [Epub ahead of print].
13. Ferguson, P.J.; Chen, S.; Tayeh, M.K.; Ochoa, L.; Leal, S.M.; Pelet, A.; Munnich, A.; Lyonnet, S.; Majeed, H.A.; El-Shanti, H. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J. Med. Genet., 2005, 42, 551-557.
14. Lindor, N.M.; Arsenault, T.M.; Solomon, H.; Seidman, C.E.; McEvoy, M.T. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo. Clin. Proc., 1997, 72, 611-615.
15. Brydges, S.; Kastner, D.L. The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr. Top. Microbiol. Immunol., 2006, 305, 127-160.
16. Ozen, S.; Hoffman, H.M.; Frenkel, J.; Kastner, D. Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA. Ann. Rheum. Dis., 2006, 65, 961-964.
17. Touitou, I.; Lesage, S.; McDermott, M.; Cuisset, L.; Hoffman, H.; Dode, C.; Shoham, N.; Aganna, E.; Hugot, J.P.; Wise, C.; Waterham, H.; Pugnere, D.; Demaille, J.; Sarrauste de Menthiere, C. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum. Mutat., 2004, 24, 194-198.
18. Jacobs, J.C.; Goetzl, E.J. Streaking leukocyte factor, arthritis, and pyoderma gangrenosum. Pediatrics, 1975, 56, 570-578.
19. Wise, C. A.; Bennett, L. B.; Pascual, V.; Gillum, J. D.; Bowcock, A. M. Localization of a gene for familial recurrent arthritis. Arthritis Rheum., 2000, 43, 2041-2045.
20. Cortis, E.; De Benedetti, F.; Insalaco, A.; Cioschi, S.; Muratori, F.; D'Urbano, L.E.; Ugazio, A.G. Abnormal production of the tumour necrosis factor alpha and clinical efficacy of the TNF Inhibitor Etanercept in a patient with PAPA syndrome. J. Pediatr., 2004, 145, 851-855.
21. Shoham, N.G.; Centola, M.; Mansfield, E.; Hull, K.M.; Wood, G.; Wise, C.A.; Kastner, D.L. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc. Natl. Acad. Sci. USA, 2003, 100, 13501-13506.
22. Edrees, A.F.; Kaplan, D.L.; Abdou, N.I. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels. J. Clin. Rheumatol., 2002, 8, 273-275.
23. Yeon, H.B.; Lindor, H.M.; Seidman, J.G.; Seidman, C.E. Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome Maps to Chromosome 15q. Am. J. Hum. Genet., 2000, 66, 1443-1448.
24. Wise, C. A.; Gillum, J.D.; Seidman, C.E.; Lindor, N.M.; Veile, R.; Bashiardes, S.; Lovett, M. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum. Mol. Genet., 2002, 11, 961-969.
25. Renn, C.N.; Helmer, A.; Megahed, M. [Pyogenic arthritis, pyoderma gangrenosum and acne syndrome (PAPA syndrome)][ Article in German] Hautarzt., 2007, 58, 383-384.
26. Tallon, B.; Corkill, M. Peculiarities of PAPA syndrome. Rheumatology (Oxford), 2006, 45, 1140-1143
27. Hong, J.B.; Su, Y.N.; Chiu, H.C. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J. Am. Acad. Dermatol., 2009, 61, 533-535.
28. André, M.F.; Aumaître, O.; Grateau, G.; Chamaillard, M.; Costedoat-Chalumeau, N.; Cardoso, M.C.; Henry-Berger, J.; Ramakrishna, B.S.; Delpech, M.; Piette, J.C.; Creveaux, I. Longest Form of CCTG Microsatellite Repeat in the Promoter of the CD2BP1/PSTPIP1 Gene Is Associated with Aseptic Abscesses and with Crohn Disease in French Patients. Dig. Dis. Sci., 2010, 55, 1681-1688.
29. Newman, B.; Cescon, D.; Domenchini, A.; Siminovitch, K.A. CD2BP1 and CARD15 mutations are not associated with pyoderma gangrenosum in patients with inflammatory bowel disease. J. Invest. Dermatol., 2004, 122, 1054-1056.
30. Wu, Y.; Dowbenko, D.; Lasky, L.A. PSTPIP 2, a second tyrosine phosphorylated, cytoskeletal-associated protein that binds a PESTtype protein-tyrosine phosphatase. J. Biol. Chem., 1998, 273, 30487-30496.
31. Tsujita, K.; Suetsugu, S.; Sasaki, N.; Furutani, M.; Oikawa, T.; Takenawa, T. Coordination between the actin cytoskeleton and membrane deformation by a novel membrane tubulation domain of PCH proteins is involved in endocytosis. J. Cell Biol., 2006, 172, 269-279.
32. Golla, A.; Jansson, A.; Ramser, J.; Hellebrand, H.; Zahn, R.; Meitinger, T.; Belohradsky, B.H.; Meindl, A. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur. J. Hum. Genet., 2002, 10, 217-221.
33. Spencer, S.; Dowbenko, D.; Cheng, J.; Li, W.; Brush, J.; Utzig, S.; Simanis, V.; Lasky, L.A. PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J. Cell Biol., 1997, 138, 845-860.
34. Li, J.; Nishizawa, K.; An, W.; Hussey, R.E.; Lialios, F.E.; Salgia, R.; Sunder-Plassmann, R.; Reinherz, E.L. A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion. EMBO J., 1998, 17, 7320-7336.
35. Angers-Loustau, A.; Côté, J.F.; Charest, A.; Dowbenko, D.; Spencer, S.; Lasky, L.A.; Tremblay, M.L. Protein tyrosine phosphatase- PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J. Cell Biol., 1999, 144, 1019-1031.
36. Côté, J.F.; Chung, P.L.; Théberge, J.F.; Hallé, M.; Spencer, S.; Lasky, L. A.; Tremblay, M. L. PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP.J. Biol. Chem., 2002, 277, 2973-2986.
37. Cong, F.; Spencer, S.; Côté, J.F.; Wu, Y.; Tremblay, M.L.; Lasky, L.A.; Goff, S.P. Cytoskeletal protein PSTPIP1 directs the PESTtype protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. Mol. Cell, 2000, 6, 1413-1423.
38. Baum, W.; Kirkin, V.; Fernández, S.B.; Pick, R.; Lettau, M.; Janssen, O.; Zörnig, M. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. J. Biol. Chem., 2005, 280, 40012-40024.
39. Qian, J.; Qian, J.; Chen, W.; Lettau, M.; Podda, G.; Zörnig, M.; Kabelitz, D.; Janssen, O. Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL. Cell Signal, 2006, 18, 1327-1337.
40. Badour, K.; Zhang, J.; Shi, F.; Leung, Y.; Collins, M.; Siminovitch, K. A. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J. Exp. Med., 2004, 199, 99-112.
41. Yang, H.; Reinherz, E. L. CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)- PEST. J. Immunol., 2006, 176, 5898-5907.
42. Cooper, K. M.; Bennin, D. A.; Huttenlocher, A. The PCH family member proline-serine-threonine phosphatase-interacting protein 1 targets to the leukocyte uropod and regulates directed cell migration. Mol. Biol. Cell, 2008, 19, 3180-3191.
43. Shiota, M.; Tanihiro, T.; Nakagawa, Y.; Aoki, N.; Ishida, N.; Miyazaki, K.; Ullrich, A.; Miyazaki, H. Protein tyrosine phosphatase PTP20 induces actin cytoskeletal reorganization by dephosphorylation p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone. Mol. Endocrinol., 2003, 17, 534-549.
44. Garton, A. J.; Tonks, N. K. PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J., 1994, 13, 3763-3771.
45. Hallé, M.; Liu, Y.C.; Hardy, S.; Théberge, J.F.; Blanchetot, C.; Bourdeau, A.; Meng, T.C.; Tremblay, M.L. Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response. Mol. Cell Biol., 2007, 27, 1172-1190.
46. Davidson, D.; Veillette, A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J., 2001, 20, 3414-3426.
47. Veillette, A.; Rhee, I.; Souza, C. M.; Davidson, D. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders. Immunol. Rev., 2009, 228, 312-324.
48. Waite, A.L.; Schaner, P.; Richards, N.; Balci-Peynircioglu, B.; Masters, S.L.; Brydges, S.D.; Fox, M.; Hong, A., Yilmaz, E., Kastner, D.L., Reinherz, E.L., Gumucio, D.L. Pyrin modulates the intracellular distribution of PSTPIP1. PLoS One, 2009, 4, e6147.
49. Yu, J. W.; Fernandes-Alnemri, T.; Datta, P.; Wu, J.; Juliana, C.; Solorzano, L.; McCormick, M.; Zhang, Z.; Alnemri, E.S. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol. Cell, 2007, 28, 214-227.
50. Galon, J.; Aksentijevich, I.; McDermott, M.F.; O'Shea, J.J.; Kastner, D.L. TNFRSFIA mutations and autoinflammatory syndromes. Curr. Opin. Immunol., 2000, 12, 479-486.
51. Callen, J. P. Neutrophilic dermatoses. Dermatol. Clin., 2002, 20, 409-419.
52. Chae, J. J.; Komarow, H.D.; Cheng, J.; Wood, G.; Raben, N.; Liu, P.P.; Kastner, D.L. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol. Cell, 2003, 11, 591-604.
53. Pascual, V.; Chaussabel, D.; Banchereau, J. A genomic approach to human autoimmune diseases. Annu. Rev. Immunol., 2010, 28, 535-571.
54. Martinon, F.; Burns, K.; Tschopp, J. The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro-IL-1. Mol. Cell, 2002, 10, 417-426.
55. Fernandes-Alnemri, T.; Wu, J.; Yu, J.W.; Datta, P.; Miller, B.; Jankowski, W.; Rosenberg, S.; Zhang, J.; Alnemri, E.S. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ., 2007, 14, 1590-1604.
56. Ryan, J. G.; Masters, S. L.; Booty, M. G.; Habal, N.; Alexander, J. D.; Barham, B. K.; Remmers, E. F.; Barron, K. S.; Kastner, D. L.; Aksentijevich, I. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann. Rheum. Dis., 2010, 69, 1383-1388.
57. Brenner, M.; Ruzicka, T.; Plewig, G.; Thomas, P.; Herzer, P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. British J. Dermatol., 2006, 161, 1199-1201.
58. Dierselhuis, M. P.; Frenkel, J.; Wulffraat, N. M.; Boelens, J. J. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatol., 2005, 44, 406-408.
59. Stichweh, D. S.; Punaro, M.; Pascual, V. Dramatic improvement of pyoderma ganrenosum with infliximab in a patient with PAPA syndrome. Ped. Derm., 2005, 22, 262-265.
60. Edrees, A. F.; Kaplan, D. L.; Abdou, N. I. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels. J. Clin. Rheumatol., 2002, 8, 273-275.
61. Cortis, E.; De Benedetti, F.; Insalaco, A.; Cioschi, S.; Muratori, F.; D'Urbano, L. E.; Ugazio, A.G. Abnormal production of tumor necrosis factor (TNF) -- alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected] J. Pediatr., 2004, 145, 851-855.
62. Cortesio, C.L.; Cooper, K.M.; Wernimont, S. A.; Kastner, D.L.; Huttenlocher, A. Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome. Arthritis Rheum., 2010 [Epub ahead of print].
63. Pascual, V.; Allantaz, F.; Arce, E.; Punaro, M.; Banchereau, J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockage. J. Exp. Med., 2005, 201, 1479-1486
64. Allantaz, F.; Chaussabel, D.; Stichweh, D.; Bennett, L.; Allman, W.; Mejias, A.; Ardura, M.; Chung, W.; Smith, E.; Wise, C.; Palucka, K.; Ramilo, O.; Punaro, M.; Banchereau, J.; Pascual, V. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J. Exp. Med., 2007, 204, 2131-2144.
65. Allantaz, F.; Chaussabel, D.; Banchereau, J.; Pascual, V. Microarray- based identification of novel biomarkers in IL-1-mediated diseases. urr. Opin. Immunol., 2007, 19, 623-632.
66. Bennett, L.; Palucka, A.K.; Arce, E.; Cantrell, V.; Borvak, J.; Banchereau, J.; Pascual, V. Interferon and Granulopoiesis signatures in systemic lupus erythematosus. J. Exp. Med., 2003, 197, 711-723.
67. Chaussabel, D.; Allman, W.; Mejias, A.; Chung, W.; Bennett, L.; Ramilo, O.; Pascual, V.; Palucka, A.K.; Banchereau, J. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes. Ann. N.Y. Acad. Sci., 2005, 1062, 146-154.
68. Chaussabel, D.; Quinn, C.; Shen, J.; Patel, P.; Glaser, C.; Baldwin, N.; Stichweh, D.; Blankenship, D.; Li, L.; Munagala, I.; Bennett, L.; Allantaz, F.; Mejias, A.; Ardura, M.; Kaizer, E.; Monnet, L.; Allman, W.; Randall, H.; Johnson, D.; Lanier, A.; Punaro, M.; Wittkowski, K.M.; White, P.; Fay, J.; Klintmalm, G.; Ramilo, O.; Palucka, A.K.; Banchereau, J.; Pascual, V. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity, 2008, 29, 150-164.